Fig. 1.

High pGSN expression is associated with tumor recurrence in patients with ovarian cancer. a Ovarian cancer public datasets were stratified using histological subtype (serous and endometroid), chemotherapeutic agents, and suboptimal surgical debulking. Kaplan–Meier survival analysis and beeswarm plots with optimal cutoff values of pGSN expression were performed on b only serous patients, c serous and endometroid patients, d serous patients with suboptimal surgical debulking, and e serous and endometroid patients with suboptimal surgical debulking with treatments containing either platinum or platinum + taxol. P values were calculated by the log-rank test